Jefferies Financial Group’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Jefferies Financial Group’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,348	Closed	-$1.29K	–	2126
2023 Q1	$1.29K	Hold	18,348	–	–	﹤0.01%	1577
2022 Q4	$3K	Buy	+18,348	New	+$2.11K	﹤0.01%	1492

Jefferies Financial Group's ORIAW Position: Q2 2023 in Review

Jefferies Financial Group sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 18,348 shares — an estimated $1.29K sold.

Jefferies Financial Group first reported a position in ORIAW in Q4 2022 and held it in 2 quarters. The position peaked at $3K in Q4 2022. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

Jefferies Financial Group reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Jefferies Financial Group sold 18,348 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $1.29K.
Jefferies Financial Group first reported a position in Orion Biotech Opportunities Corp. Warrant in Q4 2022 and held it in 2 quarters.
Jefferies Financial Group's Orion Biotech Opportunities Corp. Warrant position peaked at $3K in Q4 2022.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on Jefferies Financial Group's 13F filing for Q2 2023, filed 14 Aug 2023.